To predict the efficacy of Dadimadi Ghruta as an add on therapy in chemotherapy induced anemia (low Hb levels)

A Single arm clinical study to assess efficacy of Dadimadi Ghruta as an add on therapy in chemotherapy induced anemia

Status

Active, not recruiting

Phases

Phase 1Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2022/03/040862

Enrollment

Registered

2022-03-07

Start date

Unknown

Completion date

Unknown

Last updated

2022-04-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: D638- Anemia in other chronic diseases classified elsewhere

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: Post Chemotherapy patients on hematinic for one month without significant change in hemoglobin level hemoglobin in female less than 12 gm/dl hemoglobin in male less than 13.5 gm/dl

Exclusion criteria

Exclusion criteria: Patients contra indicated for snehapana Patients having thalassemia, sickle cell anemia and leukemia Patients with low hemoglobin levels before chemotherapy

Design outcomes

Primary

Measure	Time frame
Dadimadi Ghruta is effective in management of Chemotherapy induced Anemia.(to check increase in Haemoglobin levels in chemotherapy induced Anemia patients.)Timepoint: 30 days study with follow up on 15th and 30th day.	—

Secondary

Measure	Time frame
positive change in quality lifeTimepoint: positive lifestyle changes	—

Countries

India

Contacts

Public ContactDr Shital Rahul Rasane

Dr. D. Y. Patil college of Ayurved and Research center, Pimpri, Pune

shitalrasane@gmail.com9503330831

Outcome results